AR104835A1 - Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas - Google Patents

Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas

Info

Publication number
AR104835A1
AR104835A1 ARP160101589A ARP160101589A AR104835A1 AR 104835 A1 AR104835 A1 AR 104835A1 AR P160101589 A ARP160101589 A AR P160101589A AR P160101589 A ARP160101589 A AR P160101589A AR 104835 A1 AR104835 A1 AR 104835A1
Authority
AR
Argentina
Prior art keywords
inositol
kcal
same
high level
compositions containing
Prior art date
Application number
ARP160101589A
Other languages
English (en)
Inventor
Hondmann Dirk
Rudolph Colin
Xiao Yan
Kuang Chenzhong
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR104835A1 publication Critical patent/AR104835A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/64—Sugar alcohols
    • A23V2250/641—Inositol

Abstract

Un método para mejorar la salud y el desarrollo neurológico en un sujeto que involucra la administración de una composición nutricional a un sujeto pediátrico incluyendo no más de aproximadamente 7 g/100 kcal de una fuente de lípido o grasa; no más de aproximadamente 7 g/100 kcal de una fuente de proteína o proteína equivalente; por lo menos aproximadamente 5 g/100 kcal de un carbohidrato; y por lo menos aproximadamente 9 mg/100 kcal del inositol, en donde la proporción de inositol exógeno con respecto al inositol inherente es de por lo menos 50:50.
ARP160101589A 2015-06-03 2016-05-31 Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas AR104835A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/729,132 US10525016B2 (en) 2015-06-03 2015-06-03 Nutritional compositions containing an elevated level of inositol and uses thereof

Publications (1)

Publication Number Publication Date
AR104835A1 true AR104835A1 (es) 2017-08-16

Family

ID=55919923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101589A AR104835A1 (es) 2015-06-03 2016-05-31 Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas

Country Status (12)

Country Link
US (2) US10525016B2 (es)
EP (1) EP3302102A1 (es)
CN (1) CN107660124A (es)
AR (1) AR104835A1 (es)
AU (1) AU2016271185A1 (es)
BR (1) BR112017025339A2 (es)
CA (1) CA2987905A1 (es)
HK (1) HK1250132A1 (es)
MX (1) MX2017015037A (es)
PH (1) PH12017502181A1 (es)
TW (1) TW201707582A (es)
WO (1) WO2016195888A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180161292A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) * 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
MX2020007192A (es) * 2017-12-01 2020-08-24 Nestle Sa Composicion fortificadora de leche humana.
CN108653308B (zh) * 2018-05-07 2021-07-02 黑龙江中医药大学 江户樱花苷在治疗阿尔茨海默中的应用
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN112089724A (zh) * 2020-10-10 2020-12-18 新疆医科大学 一种芜菁酸性多糖brap-2的应用
EP4353261A1 (en) * 2021-06-09 2024-04-17 Hospital Sant Joan de Deu Nutraceutic combination and its use in the treatment of neurological disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
EP1092352A3 (en) 1991-01-24 2003-08-27 Martek Corporation Microbial oil mixtures and uses thereof
SE9101149D0 (sv) 1991-04-17 1991-04-17 Pharmacia Lkb Biotech Beads for down stream processing
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US5340603A (en) 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
TW282398B (es) 1993-12-22 1996-08-01 Bristol Myers Squibb Co
AU1809895A (en) 1994-02-16 1995-09-04 Pharming Bv Isolation of lactoferrin from milk
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
US6194009B1 (en) 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
US6039985A (en) 1996-11-22 2000-03-21 Princeton Nutrition, L.L.C. Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
EP1087828B1 (en) 1998-06-18 2008-09-17 Upfront Chromatography A/S Expanded bed adsorption system
AU2001258238B2 (en) 2000-05-12 2005-06-23 Upfront Chromatography A/S A bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
ATE455468T1 (de) 2001-06-01 2010-02-15 Upfront Chromatography As Fraktionierung von proteinhaltigen mischungen
US20030099722A1 (en) 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US20030134851A1 (en) 2001-10-09 2003-07-17 Baxter Jeffrey H. Methods and compositions for providing glutamine
AU2003218623B2 (en) 2002-03-07 2008-01-17 Upfront Chromatography A/S A process of isolating lactoferrin
KR20050071562A (ko) 2002-10-08 2005-07-07 아보트 러보러터리즈 글루타민을 제공하기 위한 방법 및 조성물
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7687652B2 (en) 2004-01-15 2010-03-30 Biolab Ltd Sphingomyelin, intermediates thereof and methods for preparation of same
BRPI0606249A2 (pt) 2005-01-14 2009-06-09 Solae Llc fórmula nutricional e método de alimentação de crianças humanas
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
CN102665428A (zh) 2009-12-08 2012-09-12 雀巢产品技术援助有限公司 含有益生菌和乳脂肪球膜组分的婴儿配方
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
EP2717705A1 (en) * 2011-06-08 2014-04-16 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
US20140179775A1 (en) 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
CN103379358B (zh) * 2012-04-23 2015-03-18 华为技术有限公司 评估多媒体质量的方法和装置
US9345360B2 (en) 2012-05-04 2016-05-24 Brian Sims Method of making infant formula and related devices
US9301966B2 (en) 2013-01-11 2016-04-05 Mead Johnson Nutrition Company Nutritional compositions containing magnesium threonate and uses thereof
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20150119322A1 (en) 2013-07-31 2015-04-30 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

Also Published As

Publication number Publication date
PH12017502181A1 (en) 2018-05-28
EP3302102A1 (en) 2018-04-11
BR112017025339A2 (pt) 2018-07-31
US20160354323A1 (en) 2016-12-08
CN107660124A (zh) 2018-02-02
HK1250132A1 (zh) 2018-11-30
US10525016B2 (en) 2020-01-07
MX2017015037A (es) 2018-04-13
CA2987905A1 (en) 2016-12-08
US20200085762A1 (en) 2020-03-19
WO2016195888A1 (en) 2016-12-08
AU2016271185A1 (en) 2017-11-23
TW201707582A (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
CL2019002255A1 (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas.
CL2017000201A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
MX2022008663A (es) Composiciones alergenicas mixtas y metodos de uso de las mismas.
CL2018001007A1 (es) Composiciones farmacéuticas para terapias combinadas (sol. divisional de n° 201702538).
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
AR105237A1 (es) Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
AR105190A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
AR110060A1 (es) Composiciones nutricionales que proporcionan el manejo dietético de cólicos
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
PE20151759A1 (es) Imidazopiridazinas sustituidas
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
UY36460A (es) Pirazolpiridinaminas
AR100313A1 (es) Composiciones nutricionales dirigidas a sujetos con alergias a la proteína de la leche de vaca
TW201613632A (en) Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
BR112019017393A2 (pt) formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas
EA201592003A1 (ru) Микропищевые добавки для иммунитета
BR112018013501A2 (pt) uso de um ingrediente fermentado e oligossacarídeo não digerível na manufatura de uma composição nutricional, método para aumento de secreção de imunoglobulina a em um indivíduo humano com idade de 0 a 36 e método para melhorar a defesa imunológica da mucosa em um indivíduo humano com idade de 0 a 36 meses
AR110344A1 (es) Métodos y regímenes de alimentación que comprenden la administración de composiciones nutricionales que contienen butirato dietario
AR112291A1 (es) Composición para su uso en la prevención y/o el tratamiento de la mucositis orogastrointestinal inducida por un tratamiento oncológico
BR112017019309A2 (pt) método para preparação de recheios de confeitaria
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida

Legal Events

Date Code Title Description
FB Suspension of granting procedure